Abeo Nasdaq

Abeona Therapeutics Inc.

ABEO | News | $3.41 -53.67% -116.79% 5.4M

(0.0% 1d) (-53.9% 1m) (4.6% 1y) (0.0% 2d) (-53.7% 3d) (-54.7% 7d) (436.24% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 93,280,676
http://www.abeonatherapeutics.com
Sec Filling | Patents | 88 employees

(US) Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

skin gene therapies

add to watch list Paper trade email alert is off

Press-releases

Abeona Therapeutics Provides Regulatory Update on Pz-cel
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology

| -53.67% | O: -48.23% H: 11.55% C: -10.5%
update therapeutics

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-01 (Crawled : 12:30) - globenewswire.com
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology

| -53.32% | O: -1.16% H: 7.48% C: 6.93%
nasdaq grants therapeutics employee

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 1, 2024
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology

| -53.32% | O: -1.16% H: 7.48% C: 6.93%
nasdaq grants therapeutics employee

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology

| -58.24% | O: -7.65% H: 0.0% C: 0.0%
fda year therapeutics financial results

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-05 (Crawled : 12:30) - globenewswire.com
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology

| -57.48% | O: -4.86% H: 0.0% C: 0.0%
nasdaq grants therapeutics employee

Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
RLMD | $3.91 1.03% 1.02% 140K

Health Technology

| -27.59% | O: 1.11% H: 1.47% C: -6.04%
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology

| -21.25% | O: 1.62% H: 0.0% C: 0.0%
pharma financial

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-01 (Crawled : 21:00) - globenewswire.com
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology

| -21.88% | O: -2.86% H: 5.42% C: 4.25%
nasdaq grants therapeutics employee

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
Published: 2024-02-01 (Crawled : 12:30) - globenewswire.com
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology

| -22.76% | O: -1.13% H: 0.0% C: 0.0%
license update application therapeutics

Abeona Therapeutics Announces $50 Million Credit Facility
Published: 2024-01-08 (Crawled : 12:30) - globenewswire.com
ABEO | News | $3.41 -53.67% -116.79% 5.4M

Health Technology